PLUS1
5.00
0.30 (6.38%)
0.30 (6.38%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 119,436 |
|
|||||
| News | - | ||||||
| Day High | 5.18 | Low High |
|||||
| Day Low | 4.77 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Gelesis Holdings Inc | GLS | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.30 | 6.38% | 5.00 | 17:21:48 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.80 | 4.77 | 5.18 | 5.00 | 4.70 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,154 | 119,436 | $ 4.99 | $ 595,841 | - | 2.55 - 8.24 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:00:00 | 2,055 | $ 5.00 | USD |
Period:
Draw Mode:
Gelesis Holdings Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 361.95M | 72.39M | 19.42M | $ 11.19M | $ - | -2.60 | -1.90 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 9.83k | 0.90% |
Gelesis News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GLS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.08 | 5.32 | 4.21 | 4.66 | 83,066 | -0.08 | -1.57% |
| 1 Month | 4.98 | 5.67 | 4.19 | 4.79 | 92,308 | 0.02 | 0.4% |
| 3 Months | 2.72 | 6.25 | 2.55 | 3.75 | 362,836 | 2.28 | 83.82% |
| 6 Months | 7.36 | 8.24 | 2.55 | 3.93 | 310,353 | -2.36 | -32.07% |
| 1 Year | 7.36 | 8.24 | 2.55 | 3.93 | 310,353 | -2.36 | -32.07% |
| 3 Years | 7.36 | 8.24 | 2.55 | 3.93 | 310,353 | -2.36 | -32.07% |
| 5 Years | 7.36 | 8.24 | 2.55 | 3.93 | 310,353 | -2.36 | -32.07% |
Gelesis Description
| Gelesis Holdings Inc is a biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Its portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH), and Functional Constipation. |
